Financials
- Market Capitalization 1.47 B
- Employee 221
- Founded 1998
- CEO Matt Kapusta
- Website www.uniqure.com
- Headquarter Netherlands
- FIGI UNKNOWN
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-6.92
Fiyat/satışlar oranı
85.48
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2125 | STOK Stoke Therapeutics, Inc. - Common Stock | 23.55 USD | -2.48% | -2.48% | -19.84% | -22.46% | 1.52 B USD | ||
| 2128 | INVA Innoviva, Inc. - Common Stock | 21.36 USD | -0.42% | +2.84% | +2.05% | +19.87% | 1.54 B USD | ||
| 2140 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 15.19 USD | -0.72% | +5.12% | +5.19% | -52.46% | 1.50 B USD | ||
| 2150 | IMCR Immunocore Holdings plc - American Depositary Shares | 28.42 USD | -2.13% | -4.79% | -13.88% | -15.11% | 1.46 B USD |